351 related articles for article (PubMed ID: 18221984)
1. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Nesher G; Berkun Y; Mates M; Baras M; Rubinow A; Sonnenblick M
Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
[TBL] [Abstract][Full Text] [Related]
5. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
Arthritis Rheum; 2004 Aug; 51(4):652-5. PubMed ID: 15334440
[TBL] [Abstract][Full Text] [Related]
6. Cancer in biopsy-proven giant cell arteritis. A population-based study.
Gonzalez-Gay MA; Lopez-Diaz MJ; Martinez-Lado L; Peña-Sagredo JL; Lopez-Agreda H; Miranda-Filloy JA; Gonzalez-Juanatey C; Sanchez-Andrade A; Martin J; Llorca J
Semin Arthritis Rheum; 2007 Dec; 37(3):156-63. PubMed ID: 17509668
[TBL] [Abstract][Full Text] [Related]
7. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
[TBL] [Abstract][Full Text] [Related]
8. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
J Rheumatol; 2003 Jul; 30(7):1548-51. PubMed ID: 12858456
[TBL] [Abstract][Full Text] [Related]
9. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.
Cid MC; Font C; Oristrell J; de la Sierra A; Coll-Vinent B; López-Soto A; Vilaseca J; Urbano-Márquez A; Grau JM
Arthritis Rheum; 1998 Jan; 41(1):26-32. PubMed ID: 9433866
[TBL] [Abstract][Full Text] [Related]
10. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
[TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
12. Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern europe.
Gonzalez-Gay MA; Boiardi L; Garcia-Porrua C; Macchioni P; Amor-Dorado JC; Salvarani C
J Rheumatol; 2004 Mar; 31(3):520-3. PubMed ID: 14994398
[TBL] [Abstract][Full Text] [Related]
13. Giant cell temporal arteritis with a normal erythrocyte sedimentation rate: report of a case.
Ciccarelli M; Jeanmonod D; Jeanmonod R
Am J Emerg Med; 2009 Feb; 27(2):255.e1-3. PubMed ID: 19371556
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
[TBL] [Abstract][Full Text] [Related]
15. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.
Gonzalez-Gay MA; Rubiera G; Piñeiro A; Garcia-Porrua C; Pego-Reigosa R; Gonzalez-Juanatey C; Sanchez-Andrade A; Llorca J
J Rheumatol; 2005 Mar; 32(3):502-6. PubMed ID: 15742443
[TBL] [Abstract][Full Text] [Related]
16. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.
Salvarani C; Hunder GG
Arthritis Rheum; 2001 Apr; 45(2):140-5. PubMed ID: 11324777
[TBL] [Abstract][Full Text] [Related]
17. Comparison of histopathologic features, clinical symptoms, and erythrocyte sedimentation rates in biopsy-positive temporal arteritis.
Diaz VA; DeBroff BM; Sinard J
Ophthalmology; 2005 Jul; 112(7):1293-8. PubMed ID: 15921755
[TBL] [Abstract][Full Text] [Related]
18. [Giant cell arteritis and normal sedimentation rate: more than an exception!].
von Blotzeim SG; Borruat FX
Klin Monbl Augenheilkd; 1996 May; 208(5):397-9. PubMed ID: 8766063
[TBL] [Abstract][Full Text] [Related]
19. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
[TBL] [Abstract][Full Text] [Related]
20. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
